37 related articles for article (PubMed ID: 2211035)
1. Dyschromatopsia and contrast sensitivity changes in COVID-19 patients.
Sharma A; Singh A; Bansal Y; Mohan A; Gnanaraj R; Khulbe P; Pangtey K; Tripathi K; Khan MA; Sharma A; Jain M
Indian J Ophthalmol; 2024 May; 72(5):664-671. PubMed ID: 38153970
[TBL] [Abstract][Full Text] [Related]
2. Vestibular Rehabilitation Considerations in an Uncommon Optic Neuritis: A Case Report.
Dangare MS; Sasun AR; Harjpal P
Cureus; 2024 Feb; 16(2):e53423. PubMed ID: 38435174
[TBL] [Abstract][Full Text] [Related]
3. Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.
Barreiro-González A; Sanz MT; Carratalà-Boscà S; Pérez-Miralles F; Alcalá C; España-Gregori E; Casanova B
Acta Neurol Belg; 2021 Dec; 121(6):1767-1775. PubMed ID: 33044738
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Normal-tension Glaucoma Patients with Temporal Retinal Nerve Fibre Defects.
Yum HR; Park HL; Park CK
Sci Rep; 2020 Apr; 10(1):6362. PubMed ID: 32286476
[TBL] [Abstract][Full Text] [Related]
5. Optic neuritis, its differential diagnosis and management.
Hoorbakht H; Bagherkashi F
Open Ophthalmol J; 2012; 6():65-72. PubMed ID: 22888383
[TBL] [Abstract][Full Text] [Related]
6. Colour vision defects in asymptomatic carriers of the Leber's hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study.
Quiros PA; Torres RJ; Salomao S; Berezovsky A; Carelli V; Sherman J; Sadun F; De Negri A; Belfort R; Sadun AA
Br J Ophthalmol; 2006 Feb; 90(2):150-3. PubMed ID: 16424523
[TBL] [Abstract][Full Text] [Related]
7. Acquired color vision loss and a possible mechanism of ganglion cell death in glaucoma.
Nork TM
Trans Am Ophthalmol Soc; 2000; 98():331-63. PubMed ID: 11190032
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes and color vision disorder detected by the Farnsworth 100 Hue test. Diabetic dyschromatopsia].
Ayed S; Jeddi A; Kallal Z
J Fr Ophtalmol; 1990; 13(10):506-10. PubMed ID: 2081841
[TBL] [Abstract][Full Text] [Related]
9. [The pathogenesis of diabetic dyschromatopsia].
Gheorghiu M
Oftalmologia; 1996; 40(1):11-5. PubMed ID: 8714105
[TBL] [Abstract][Full Text] [Related]
10. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage.
Silverman SE; Hart WM; Gordon MO; Kilo C
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1895-902. PubMed ID: 2211035
[TBL] [Abstract][Full Text] [Related]
11. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
Katz B
Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
[TBL] [Abstract][Full Text] [Related]
12. Color vision defect type and spatial vision in the optic neuritis treatment trial.
Schneck ME; Haegerstrom-Portnoy G
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
[TBL] [Abstract][Full Text] [Related]
13. Blue-on-yellow perimetry in the complete type of congenital stationary night blindness.
Terasaki H; Miyake Y; Nomura R; Horiguchi M; Suzuki S; Kondo M
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2761-4. PubMed ID: 10509678
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
